SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-17-001524
Filing Date
2017-03-15
Accepted
2017-03-15 09:01:21
Documents
53
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031517.htm 10-K 615048
2 EXHIBIT 31.1 exh_311.htm EX-31.1 6820
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6903
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3579
  Complete submission text file 0001171843-17-001524.txt   3223971

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE caps-20161231.xml EX-101.INS 526371
6 XBRL SCHEMA FILE caps-20161231.xsd EX-101.SCH 35330
7 XBRL CALCULATION FILE caps-20161231_cal.xml EX-101.CAL 30033
8 XBRL DEFINITION FILE caps-20161231_def.xml EX-101.DEF 197870
9 XBRL LABEL FILE caps-20161231_lab.xml EX-101.LAB 254629
10 XBRL PRESENTATION FILE caps-20161231_pre.xml EX-101.PRE 236251
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21214 | Film No.: 17689962
SIC: 2834 Pharmaceutical Preparations